Working… Menu
Trial record 1 of 1 for:    INCB 50465-304
Previous Study | Return to List | Next Study

To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04551053
Recruitment Status : Recruiting
First Posted : September 16, 2020
Last Update Posted : July 29, 2021
Information provided by (Responsible Party):
Incyte Corporation

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 28, 2023
Estimated Study Completion Date : December 31, 2023